| 000 | 01551 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515154508.0 | ||
| 264 | 0 | _c20090505 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1471-230X | ||
| 024 | 7 |
_a10.1186/1471-230X-9-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIdrees, Muhammad | |
| 245 | 0 | 0 |
_aA study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients. _h[electronic resource] |
| 260 |
_bBMC gastroenterology _cJan 2009 |
||
| 300 |
_a5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPakistan |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRiazuddin, Sheikh | |
| 773 | 0 |
_tBMC gastroenterology _gvol. 9 _gp. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-230X-9-5 _zAvailable from publisher's website |
| 999 |
_c18600057 _d18600057 |
||